e-learning
resources
Milan 2017
Monday, 11.09.2017
Migrants and screening
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment
E. Petruccioli (Roma, Rm, Italy)
Source:
International Congress 2017 – Migrants and screening
Session:
Migrants and screening
Session type:
Thematic Poster
Number:
2692
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Petruccioli (Roma, Rm, Italy). Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment. 2692
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Modulation of whole-blood IGRA response in patients with latent TB infection during treatment
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Impact of Quantiferon TB Gold intensity response in active over latent tuberculosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Source: Eur Respir J 2010; 36: 135-142
Year: 2010
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Characterization of the HBHA response in TB patients with or without HIV infection.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
QuantiFERON-TB Gold for detection of latent and active tuberculosis infection in immunocompromised versus immune-competent
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009
Quantiferon–TB Gold test in cases of active pulmonary tuberculosis initially and during treatment
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
Completion of treatment for latent tuberculosis infection
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Contribution of the T-SPOT.TB assay for differentiating active
versus
latent tuberculosis infection (LTBI)
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009
Interferon-gamma response by years after tuberculosis infection, measured with QuantiFERON-TB Plus
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019
Absence of response to Quantiferon-TB Gold is associated to severe tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Diagnosis and treatment of latent tuberculosis infection
Source: Eur Respir Monogr 2018; 82: 381-398
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept